PAA 4.26% 22.5¢ pharmaust limited

Yes, the value of the GMP tablets is hard to overstate, add to...

  1. 2,480 Posts.
    lightbulb Created with Sketch. 1409
    Yes, the value of the GMP tablets is hard to overstate, add to that the wealth of data on MPL from it's many years in the food chain along with pre clinical data from.

    • Leiden
    • WEHI
    • 20 years of research into MPL due to it being in the Human food chain during that time.
    • This brilliant paper released in May of this year. https://onlinelibrary.wiley.com/doi/10.1002/cam4.6021
    • The Olivier Newton John Center pre clinical work on 28 human cancers.
    • Canine Cancer clinical trials and their parallels with Human cancer.

    There is lots more we can quote, but it would take all day. The journey has been frustrating at times and no doubt some things could have been done differently, but hang in there people.

    The 900 million A$ quoted appears to be for ALS/MND, add the that Parkinsons Disease [up too 30 times more common] and things get interesting.

    An important thing I took away from MTs recent interview was the mention of his intention to take Pharmaust forward without dilution.

    Things are finally looking up.



 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.010(4.26%)
Mkt cap ! $89.08M
Open High Low Value Volume
23.5¢ 23.5¢ 22.0¢ $170.5K 749.0K

Buyers (Bids)

No. Vol. Price($)
2 34313 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 24444 2
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
22.5¢
  Change
-0.010 ( 6.25 %)
Open High Low Volume
23.0¢ 23.0¢ 22.0¢ 246904
Last updated 15.57pm 14/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.